Can we establish a hierarchy among trastuzumab biosimilar candidates?

Por Pivot, Xavier, Petit, Thierry
Publicado no Br J Cancer (2018)

Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capeci...

Por Pivot, Xavier, Im, Seock Ah, Guo, Matthew, Marmé, Frederik
Publicado no Breast Cancer (2018)

Adjuvant Trastuzumab Is Required in Human Epidermal Growth Factor Receptor 2-Positive Node-Negative Breast Cancer Patients Regardless of Tumour Size

Por Bender, Laura, Kurtz, Jean-Emmanuel, Petit, Thierry, Pivot, Xavier
Publicado no J Breast Cancer (2020)

Biologic Drug Quality Assurance to Optimize HER2 + Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3

Por Lüftner, Diana, Lyman, Gary H., Gonçalves, João, Pivot, Xavier, Seo, Minji
Publicado no Target Oncol (2020)

Correction to: Biologic Drug Quality Assurance to Optimize HER2+ Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3

Por Lüftner, Diana, Lyman, Gary H., Gonçalves, João, Pivot, Xavier, Seo, Minji
Publicado no Target Oncol (2020)

Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic H...

Por Paracha, Noman, Reyes, Adriana, Diéras, Véronique, Krop, Ian, Pivot, Xavier, Urruticoechea, Ander
Publicado no Breast Cancer Res Treat (2020)

MAINTENANCE HORMONAL TREATMENT IMPROVES PROGRESSION FREE SURVIVAL AFTER A FIRST LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST CANCER

Por Dufresne, Armelle, Pivot, Xavier, Tournigand, Christophe, Facchini, Thomas, Alweeg, Thierry, Chaigneau, Loic, De Gramont, Aimery
Publicado em 2008

Organizing medical oncology care at a regional level and its subsequent impact on the quality of early breast cancer management: a before-after study

Por Voidey, Aline, Pivot, Xavier, Woronoff, Anne-Sophie, Nallet, Gilles, Cals, Laurent, Schwetterle, Francis, Limat, Samuel
Publicado em 2014

A time and motion study of subcutaneous versus intravenous trastuzumab in patients with HER2‐positive early breast cancer

Por De Cock, Erwin, Pivot, Xavier, Hauser, Nik, Verma, Sunil, Kritikou, Persefoni, Millar, Douglas, Knoop, Ann
Publicado no Cancer Med (2016)

A phenotypic and mechanistic perspective on heterogeneity of HER2-positive breast cancers

Por Ferrari, Anthony, Sertier, Anne-Sophie, Vincent-Salomon, Anne, Pivot, Xavier, Pauporté, Iris, Saintigny, Pierre, Birnbaum, Daniel, Viari, Alain
Publicado no Mol Cell Oncol (2016)

Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer

Por Guardiola, Emmanuel, Delroeux, Delphine, Heyd, Bruno, Combe, Marielle, Lorgis, Veronique, Demarchi, Martin, Stein, Ulrich, Royer, Bernard, Chauffert, Bruno, Pivot, Xavier
Publicado em 2009

A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuv...

Por Jacquinot, Quentin, Meneveau, Nathalie, Chatot, Marion, Bonnetain, Franck, Degano, Bruno, Bouhaddi, Malika, Dumoulin, Gilles, Vernerey, Dewi, Pivot, Xavier, Mougin, Fabienne
Publicado no BMC Cancer (2017)

Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2− advanced breast cancer in five European countries

Por Davie, Alison, Carter, Gebra Cuyun, Rider, Alex, Pike, James, Lewis, Katie, Bailey, Abigail, Price, Gregory L., Ringeisen, Francois, Pivot, Xavier
Publicado no BMC Cancer (2020)

Safety and Efficacy of Cabazitaxel in the Docetaxel-Treated Patients with Hormone-Refractory Prostate Cancer

Por Calcagno, Fabien, Nguyen, Thierry, Dobi, Erion, Villanueva, Cristian, Curtit, Elsa, Kim, Stefano, Montcuquet, Philippe, Kleinclauss, François, Pivot, Xavier, Thiery-Vuillemin, Antoine
Publicado em 2012

Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review

Por Fiteni, Frédéric, Nguyen, Thierry, Vernerey, Dewi, Paillard, Marie-Justine, Kim, Stefano, Demarchi, Martin, Fein, Francine, Borg, Christophe, Bonnetain, Franck, Pivot, Xavier
Publicado no Cancer Med (2014)

Subcutaneous vs Intravenous Trastuzumab for Patients With ERBB2-Positive Early Breast Cancer: Final Analysis of the HannaH Phase 3 Randomized Clinical Trial

Por Jackisch, Christian, Stroyakovskiy, Daniil, Pivot, Xavier, Ahn, Jin Seok, Melichar, Bohuslav, Chen, Shin-Cheh, Meyenberg, Christoph, Al-Sakaff, Nedal, Heinzmann, Dominik, Hegg, Roberto
Publicado no JAMA Oncol (2019)

Beliefs and behavior regarding e-cigarettes in a large cross-sectional survey

Por Couraud, Sébastien, Cortot, Alexis B., Pivot, Xavier B., Touboul, Chantal, Lhomel, Christine, Blay, Jean-Yves, Eisinger, François, Viguier, Jérôme, Morère, Jean-François, Greillier, Laurent
Publicado no Prev Med Rep (2018)

Adjuvant Subcutaneous Trastuzumab for HER2‐Positive Early Breast Cancer: Subgroup Analyses of Safety and Active Medical Conditions by Body Weight in the SafeHer Phase III Study

Por Jung, Kyung Hae, Ataseven, Beyhan, Verrill, Mark, Pivot, Xavier, De Laurentiis, Michelino, Al‐Sakaff, Nedal, Lauer, Sabine, Shing, Mona, Gligorov, Joseph, Azim, Hamdy A.
Publicado no Oncologist (2018)

Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activation

Por Pallandre, Jean R., Krzewski, Konrad, Bedel, Romain, Ryffel, Bernhard, Caignard, Anne, Rohrlich, Pierre Simon, Pivot, Xavier, Tiberghien, Pierre, Zitvogel, Laurence, Strominger, Jack L., Borg, Christophe
Publicado em 2008

Efficacy of trabectedin in metastatic solitary fibrous tumor

Por Chaigneau, Loïc, Kalbacher, Elsa, Thiery-Vuillemin, Antoine, Fagnoni-Legat, Christine, Isambert, Nicolas, Aherfi, Lionel, Pauchot, Julien, Delroeux, Delphine, Servagi-Vernat, Stephanie, Mansi, Laura, Pivot, Xavier
Publicado em 2011